TY - JOUR
T1 - Definition of fibromyalgia severity: Findings from a cross-sectional survey of 2339 Italian patients
AU - Salaffi, Fausto
AU - Di Carlo, Marco
AU - Bazzichi, Laura
AU - Atzeni, Fabiola
AU - Govoni, Marcello
AU - Biasi, Giovanni
AU - Di Franco, Manuela
AU - Mozzani, Flavio
AU - Gremese, Elisa
AU - Dagna, Lorenzo
AU - Batticciotto, Alberto
AU - Fischetti, Fabio
AU - Giacomelli, Roberto
AU - Guiducci, Serena
AU - Guggino, Giuliana
AU - Bentivegna, Mario
AU - Bentivegna, Michela
AU - Gerli, Roberto
AU - Salvarani, Carlo
AU - Bajocchi, Gianluigi
AU - Ghini, Marco
AU - Iannone, Florenzo
AU - Giorgi, Valeria
AU - Farah, Sonia
AU - Cirillo, Mariateresa
AU - Bonazza, Sara
AU - Barbagli, Stefano
AU - Gioia, Chiara
AU - Santilli, Daniele
AU - Santilli, Domenico
AU - Capacci, Annunziata
AU - Cavalli, Giulio
AU - Cavalli, Giulia
AU - Carubbi, Francesco
AU - Nacci, Francesca
AU - Riccucci, Ilenia
AU - Sinigaglia, Luigi
AU - Masullo, Maurizio
AU - Masullo, Matteo
AU - Polizzi, Bianca Maria
AU - Cutolo, Maurizio
AU - Sarzi-Puttini, Piercarlo
PY - 2021
Y1 - 2021
N2 - Objective: To establish optimal cut-off values for the scores of the revised Fibromyalgia Impact Questionnaire (FIQR), the modified Fibromialgia Assessment Scale (FAS 2019mod), and the Polysymptomatic Distress Scale (PDS) in order to distinguish five levels of FM disease severity. Methods: Consecutive FM patients were evaluated with the three clinimetric indices, and each patient was required to answer the anchor question: 'In general, would you say your health is 1 = very good, 2 = good, 3 = fair, 4 = poor, or 5 = very poor?'-which represented the external criterion. Cut-off points were established through the interquartile reconciliation approach. Results: The study sample consisted of 2181 women (93.2%) and 158 men (6.8%), with a mean age of 51.9 (11.5) years, and mean disease duration was 7.3 (6.9) years. The overall median FIQR, FAS 2019 mod and PDS scores (25th-75th percentiles) were respectively 61.16 (41.16-77.00), 27.00 (19.00-32.00) and 19.0 (13.00-24.00). Reconciliation of the mean 75th and 25th percentiles of adjacent categories defined the severity states for FIQR: 0-23 for remission, 24-40 for mild disease, 41-63 for moderate disease, 64-82 for severe disease and >83 for very severe disease; FAS 2019 mod: 0-12 for remission, 13-20 for mild disease, 21-28 for moderate disease, 29-33 for severe disease and >33 for very severe disease; PDS: 0-5 for remission, 6-15 for mild disease, 16-20 for moderate disease, 21-25 for severe disease and >25 for very severe disease. Conclusions: Disease severity cut-offs can represent an important improvement in interpreting FM.
AB - Objective: To establish optimal cut-off values for the scores of the revised Fibromyalgia Impact Questionnaire (FIQR), the modified Fibromialgia Assessment Scale (FAS 2019mod), and the Polysymptomatic Distress Scale (PDS) in order to distinguish five levels of FM disease severity. Methods: Consecutive FM patients were evaluated with the three clinimetric indices, and each patient was required to answer the anchor question: 'In general, would you say your health is 1 = very good, 2 = good, 3 = fair, 4 = poor, or 5 = very poor?'-which represented the external criterion. Cut-off points were established through the interquartile reconciliation approach. Results: The study sample consisted of 2181 women (93.2%) and 158 men (6.8%), with a mean age of 51.9 (11.5) years, and mean disease duration was 7.3 (6.9) years. The overall median FIQR, FAS 2019 mod and PDS scores (25th-75th percentiles) were respectively 61.16 (41.16-77.00), 27.00 (19.00-32.00) and 19.0 (13.00-24.00). Reconciliation of the mean 75th and 25th percentiles of adjacent categories defined the severity states for FIQR: 0-23 for remission, 24-40 for mild disease, 41-63 for moderate disease, 64-82 for severe disease and >83 for very severe disease; FAS 2019 mod: 0-12 for remission, 13-20 for mild disease, 21-28 for moderate disease, 29-33 for severe disease and >33 for very severe disease; PDS: 0-5 for remission, 6-15 for mild disease, 16-20 for moderate disease, 21-25 for severe disease and >25 for very severe disease. Conclusions: Disease severity cut-offs can represent an important improvement in interpreting FM.
KW - Cross-Sectional Studies
KW - Female
KW - Fibromyalgia
KW - Fibromyalgia Assessment Status
KW - Follow-Up Studies
KW - Humans
KW - Incidence
KW - Italy
KW - Male
KW - Middle Aged
KW - Pain Measurement
KW - Prognosis
KW - Quality of Life
KW - Retrospective Studies
KW - Severity of Illness Index
KW - Surveys and Questionnaires
KW - cut-off points
KW - fibromyalgia
KW - modified
KW - polysymptomatic distress scale
KW - revised Fibromyalgia Impact Questionnaire
KW - severity
KW - Cross-Sectional Studies
KW - Female
KW - Fibromyalgia
KW - Fibromyalgia Assessment Status
KW - Follow-Up Studies
KW - Humans
KW - Incidence
KW - Italy
KW - Male
KW - Middle Aged
KW - Pain Measurement
KW - Prognosis
KW - Quality of Life
KW - Retrospective Studies
KW - Severity of Illness Index
KW - Surveys and Questionnaires
KW - cut-off points
KW - fibromyalgia
KW - modified
KW - polysymptomatic distress scale
KW - revised Fibromyalgia Impact Questionnaire
KW - severity
UR - http://hdl.handle.net/10807/205443
U2 - 10.1093/rheumatology/keaa355
DO - 10.1093/rheumatology/keaa355
M3 - Article
SN - 1462-0324
VL - 60
SP - 728
EP - 736
JO - Rheumatology
JF - Rheumatology
ER -